Keratitis Clinical Trial
Official title:
Repeatability and Reproducibility of Pachymetric Mapping With Fourier Domain Optical Coherence Tomography, Ocular Response Analyzer, Confoscan 4 and Ultrasound
The purpose of this study is to assess the repeatability, reproducibility, and agreement of central corneal thickness measured by Fourier Domain Optical Coherence tomography (FD-OCT, OptoVue, USA) with anterior corneal module, 20MHz ultrasound pachymetry equipped with Ocular response analyzer (ORA, Reichert Ophthalmic Instruments, USA) and 10MHz Ultrasound Pachymetry (USP).
Corneal thickness measurements are clinically important. Variation in corneal thickness affects the accuracy of applanation tonometry. A meta-analysis by Doughty and Zaman showed that a 10% change in central corneal thickness may result in an approximately 3.4-mmHg change in intraocular pressure.1 Accuracy of corneal thickness measurement is also important in considering eligibility for refractive surgery, and the amount of correction that can safely be performed. Underestimation of corneal thickness may lead to eligible patients being excluded for primary or enhancement refractive procedures. Overestimation may lead to over-ablation and inadvertent thinning of the stroma, thereby increasing the risk of iatrogenic keratectasia. Hence, studies assessing corneal thickness measurements by various instruments are of high clinical relevance.2-9 Fourier domain optical coherence tomography (FD-OCT, OptoVue, U.S.A), Confoscan 4 (CS-4, Nidek, USA) and ocular response analyzer (ORA, Reichert, USA) are non-invasive medical devices that have recently received FDA approval for measurement of the cornea thickness. However, the repeatability and reproducibility of these instruments remains unproven in the clinical settings. To our knowledge, this is the first study to describe agreement, repeatability and reproducibility in corneal pachymetric mapping between FD-OCT, ORA, CS-4 and conventional ultrasound (US), which has been the current reference corneal pachymetric mapping system for the majority of refractive surgeons. ;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00513734 -
A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill
|
N/A | |
Enrolling by invitation |
NCT03436576 -
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
|
Phase 3 | |
Recruiting |
NCT06229379 -
The Effects of a Large Language Model on Clinical Questioning Skills
|
N/A | |
Completed |
NCT01268306 -
Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses
|
Phase 4 | |
Completed |
NCT01028027 -
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
|
Phase 3 | |
Recruiting |
NCT05432336 -
Complex Ocular Infection, Optimization of Microbiological Diagnosis
|
||
Completed |
NCT04169061 -
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
|
Phase 4 | |
Completed |
NCT03237936 -
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
|
Phase 4 | |
Completed |
NCT00001734 -
Screening for NEI Clinical Studies
|
N/A | |
Recruiting |
NCT05255016 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
|
Phase 2/Phase 3 | |
Recruiting |
NCT05255107 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
|
Phase 2/Phase 3 | |
Terminated |
NCT05250583 -
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis
|
Phase 2 | |
Recruiting |
NCT02865876 -
Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis
|
Phase 3 | |
Terminated |
NCT02116062 -
Robotic Surgery of the Ocular Surface
|
N/A | |
Completed |
NCT00949468 -
Microbiological Keratitis in a Countryside City of Brazil
|
N/A | |
Completed |
NCT03586505 -
Tolerance to Light for Patients Suffering From Keratitis
|
N/A | |
Recruiting |
NCT04420962 -
Automated Quantitative Ulcer Analysis Study
|
||
Completed |
NCT02186431 -
Contact Lenses and Infiltrative Keratitis
|
N/A | |
Completed |
NCT05538793 -
Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
|
||
Not yet recruiting |
NCT05689996 -
Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
|
Phase 3 |